ArticleJMIR human factors2025
Mobile Health App for Adults with Persisting Postconcussion Symptoms: Development and Usability Study.
Article in JMIR human factors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diagnostics, treatment, and research of persisting postconcussion symptoms are challenging. Assessing symptoms is essential, but currently implemented methods only allow for retrospective reporting of symptoms. A mobile health (mHealth) symptom mapping app for adults with persisting postconcussion symptoms may be an accessible and cost-efficient alternative. Objective: This study aimed to develop a research-based mobile app for symptom mapping for adults with persisting postconcussion symptoms and investigate its usability, feasibility, and safety. Methods: This was a mixed method development and usability study consisting of three iterative cycles, each including (1) app design and programming, (2) app usability evaluation by the user group, and (3) app review by the clinician group. The outcomes were the mHealth App Usability Questionnaire and Mobile App Rating Scale scores, the number of days with logged symptom data during a home-testing period, and descriptions of adverse events throughout the study period. Semistructured interviews were conducted to explore the user group's experiences further. Results: Twenty-three adults with persisting postconcussion symptoms (median age 52, IQR 34-59 years; 70% female) were included in the user group. Six clinicians (median age 53, IQR 35-60 years), including 3 (50%) females, with a mean of 13 (SD 7) years of experience working with individuals with persisting postconcussion symptoms, were included in the clinician group. The app received a mean score of 5 (SD 1.1) on the mHealth App Usability Questionnaire (7-point Likert scale) from the user group and 4.1 (SD 0.4) on the Mobile App Rating Scale (5-point Likert Scale) from the clinician group. During the 28-day home-testing period, the adherence rate among the participants in the user group was 89% (IQR 78-96), and two adverse events related to increased symptom awareness were registered. Three themes were created through reflexive thematic analysis of the qualitative data: (1) Visualizing the invisible-Enabling reflection and insight; (2) Personalized yet simple-Balancing relevance and usefulness; and (3) More than just a number-The complexity behind the symptom scores. Conclusions: We developed a research-based symptom mapping app for people with persisting postconcussion symptoms. The app received high usability ratings from both the user and clinician groups. The app is a feasible alternative to traditional symptom mapping methods, and it is safe to use for its intended purpose.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.